General Information of Drug Transporter (DT)
DT ID DTD0052 Transporter Info
Gene Name ABCB6
Transporter Name ATP-binding cassette sub-family B member 6
Gene ID
10058
UniProt ID
Q9NP58
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Chemical Compound

  DT Modulation1

ABCB6 mRNA affects the susceptibility to Cisplatin [42]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Cisplatin co-treated with jinfukang results in increased expression of ABCB6 mRNA [23]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Cisplatin results in increased expression of ABCB6 mRNA [5]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

ABCB6 protein results in decreased susceptibility to Fluorouracil [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Cyclosporine results in increased expression of ABCB6 mRNA [46]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of ABCB6 mRNA [34]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Valproic Acid affects the expression of ABCB6 mRNA [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of ABCB6 mRNA [34]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Benzo(a)pyrene results in increased methylation of ABCB6 5' UTR [38]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Benzo(a)pyrene results in increased methylation of ABCB6 promoter [38]

Regulation Mechanism

Transcription Factor Info

  4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide

           4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of ABCB6 mRNA [34]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of ABCB6 mRNA [34]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of ABCB6 mRNA [34]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of ABCB6 mRNA [34]

Regulation Mechanism

Transcription Factor Info

  9,10-dihydro-9,10-dihydroxybenzo(a)pyrene

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

9,10-dihydro-9,10-dihydroxybenzo(a)pyrene results in increased expression of ABCB6 mRNA [32]

Regulation Mechanism

Transcription Factor Info

  abrine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

abrine results in decreased expression of ABCB6 mRNA [35]

Regulation Mechanism

Transcription Factor Info

  Amitrole

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ABCB6 inhibits the reaction Amitrole results in decreased activity of CAT protein which results in increased susceptibility to sodium arsenite [36]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Amitrole inhibits the reaction ABCB6 protein results in increased activity of CAT protein [36]

Regulation Mechanism

Transcription Factor Info

  beta-Naphthoflavone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

beta-Naphthoflavone results in increased expression of ABCB6 mRNA [29]

Regulation Mechanism

Transcription Factor Info

  bisphenol A

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bisphenol A results in increased expression of ABCB6 mRNA [26]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

bisphenol A results in increased expression of ABCB6 protein [39]

Regulation Mechanism

Transcription Factor Info

  bisphenol S

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bisphenol S results in increased expression of ABCB6 protein [39]

Regulation Mechanism

Transcription Factor Info

  Cadmium Chloride

           4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ABCB6 protein inhibits the reaction HMT-1 gene mutant form results in increased susceptibility to Cadmium Chloride [41]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

ABCB6 protein results in decreased susceptibility to Cadmium Chloride [41]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Cadmium Chloride results in increased abundance of Cadmium which results in increased expression of ABCB6 mRNA [40]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Cadmium Chloride results in increased expression of ABCB6 mRNA [5]

Regulation Mechanism

Transcription Factor Info

  chloroacetaldehyde

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

chloroacetaldehyde affects the expression of ABCB6 mRNA [5]

Regulation Mechanism

Transcription Factor Info

  clothianidin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

clothianidin results in decreased expression of ABCB6 mRNA [25]

Regulation Mechanism

Transcription Factor Info

  Cobalt

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

tungsten carbide co-treated with Cobalt results in increased expression of ABCB6 mRNA [43]

Regulation Mechanism

Transcription Factor Info

  cobaltous chloride

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

cobaltous chloride results in increased expression of ABCB6 mRNA [44]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

zinc chloride inhibits the reaction cobaltous chloride results in increased expression of ABCB6 mRNA [45]

Regulation Mechanism

Transcription Factor Info

  deoxynivalenol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

deoxynivalenol results in decreased expression of ABCB6 protein [47]

Regulation Mechanism

Transcription Factor Info

  Docetaxel

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Docetaxel results in decreased susceptibility to Docetaxel which results in increased expression of ABCB6 mRNA [48]

Regulation Mechanism

Transcription Factor Info

  dorsomorphin

           4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of ABCB6 mRNA [34]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of ABCB6 mRNA [34]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of ABCB6 mRNA [34]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of ABCB6 mRNA [34]

Regulation Mechanism

Transcription Factor Info

  Estradiol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Estradiol results in increased expression of ABCB6 mRNA [49]

Regulation Mechanism

Transcription Factor Info

  glycidamide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

glycidamide results in increased expression of ABCB6 mRNA [16]

Regulation Mechanism

Transcription Factor Info

  Heme

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Heme results in increased expression of ABCB6 mRNA [51]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Heme results in increased expression of ABCB6 protein [51]

Regulation Mechanism

Transcription Factor Info

  ICG 001

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ICG 001 results in decreased expression of ABCB6 mRNA [21]

Regulation Mechanism

Transcription Factor Info

  Irinotecan

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ABCB6 protein results in decreased susceptibility to Irinotecan [50]

Regulation Mechanism

Transcription Factor Info

  Manganese

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

sodium arsenite results in increased abundance of Arsenic co-treated with manganese chloride results in increased abundance of Manganese results in increased expression of ABCB6 mRNA [37]

Regulation Mechanism

Transcription Factor Info

  manganese chloride

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

sodium arsenite results in increased abundance of Arsenic co-treated with manganese chloride results in increased abundance of Manganese results in increased expression of ABCB6 mRNA [37]

Regulation Mechanism

Transcription Factor Info

  mercuric bromide

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

mercuric bromide results in increased expression of ABCB6 mRNA [22]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of ABCB6 mRNA [34]

Regulation Mechanism

Transcription Factor Info

  methylmercuric chloride

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

methylmercuric chloride results in increased expression of ABCB6 mRNA [13]

Regulation Mechanism

Transcription Factor Info

  Methyl Methanesulfonate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Methyl Methanesulfonate results in increased expression of ABCB6 mRNA [19]

Regulation Mechanism

Transcription Factor Info

  Oxygen

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Oxygen deficiency results in increased expression of ABCB6 mRNA [5]

Regulation Mechanism

Transcription Factor Info

  p-Chloromercuribenzoic Acid

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of ABCB6 mRNA [34]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

p-Chloromercuribenzoic Acid results in increased expression of ABCB6 mRNA [22]

Regulation Mechanism

Transcription Factor Info

  Silicon Dioxide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Silicon Dioxide analog results in decreased expression of ABCB6 mRNA [52]

Regulation Mechanism

Transcription Factor Info

  sodium arsenite

           7 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ABCB6 inhibits the reaction Amitrole results in decreased activity of CAT protein which results in increased susceptibility to sodium arsenite [36]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

ABCB6 protein results in decreased susceptibility to sodium arsenite [36]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

sodium arsenite results in decreased expression of ABCB6 mRNA [53]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

sodium arsenite results in increased abundance of Arsenic co-treated with manganese chloride results in increased abundance of Manganese results in increased expression of ABCB6 mRNA [37]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

sodium arsenite results in increased abundance of Arsenic which results in increased expression of ABCB6 mRNA [37]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

sodium arsenite results in increased expression of ABCB6 mRNA [36]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

sodium arsenite results in increased expression of ABCB6 protein [36]

Regulation Mechanism

Transcription Factor Info

  Sodium Dodecyl Sulfate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Sodium Dodecyl Sulfate results in decreased expression of ABCB6 mRNA [54]

Regulation Mechanism

Transcription Factor Info

  sulforaphane

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

sulforaphane results in increased expression of ABCB6 mRNA [27]

Regulation Mechanism

Transcription Factor Info

  Tetrachlorodibenzodioxin

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tetrachlorodibenzodioxin affects the expression of ABCB6 mRNA [55]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Tetrachlorodibenzodioxin results in increased expression of ABCB6 mRNA [46]

Regulation Mechanism

Transcription Factor Info

  tungsten carbide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

tungsten carbide co-treated with Cobalt results in increased expression of ABCB6 mRNA [43]

Regulation Mechanism

Transcription Factor Info

  Vincristine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ABCB6 protein results in decreased susceptibility to Vincristine [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Vincristine results in decreased susceptibility to Vincristine which affects the expression of ABCB6 mRNA [48]

Regulation Mechanism

Transcription Factor Info

  zinc chloride

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

zinc chloride inhibits the reaction cobaltous chloride results in increased expression of ABCB6 mRNA [45]

Regulation Mechanism

Transcription Factor Info

Mycotoxins

  ochratoxin A

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ochratoxin A results in decreased expression of ABCB6 mRNA [17]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

ochratoxin A results in decreased expression of ABCB6 protein [47]

Regulation Mechanism

Transcription Factor Info

Approved Drug

  Phenobarbital

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Phenobarbital affects the expression of ABCB6 [2]

  Cisplatin

           4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cisplatin inhibits the expression of ABCB6 [3]

  Fluorouracil

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Fluorouracil inhibits the expression of ABCB6 [3]

  Paclitaxel

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Paclitaxel inhibits the expression of ABCB6 [3]

  Cyclosporine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cyclosporine inhibits the expression of ABCB6 [4]

  Cidofovir

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cidofovir increases the expression of ABCB6 [5]

  Ifosfamide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ifosfamide increases the expression of ABCB6 [5]

  Rifampin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Rifampin increases the expression of ABCB6 [6]

  Urethane

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Urethane inhibits the expression of ABCB6 [7]

  Sunitinib

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Sunitinib increases the expression of ABCB6 [8]

  Temozolomide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Temozolomide increases the expression of ABCB6 [9]

  Ivermectin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ivermectin inhibits the expression of ABCB6 [10]

  Cannabidiol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cannabidiol inhibits the expression of ABCB6 [11]

  Acetaminophen

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Acetaminophen inhibits the expression of ABCB6 [12]

  Valproic Acid

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Valproic Acid increases the expression of ABCB6 [13]

  Zoledronic Acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Zoledronic Acid inhibits the expression of ABCB6 [5]

  Leflunomide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Leflunomide inhibits the expression of ABCB6 [14]

  Verteporfin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Verteporfin inhibits the activity of ABCB6 [15]

Drug in Phase 3 Trial

  Sulforafan

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Sulforafan increases the expression of ABCB6 [27]

Drug in Phase 2 Trial

  Bisphenol A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Bisphenol A increases the expression of ABCB6 [26]

Drug in Phase 1 Trial

  Sodium arsenite

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Sodium arsenite increases the expression of ABCB6 [33]

Investigative Drug

  Phenylmercuric Acetate

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Phenylmercuric Acetate increases the expression of ABCB6 [22]

  Beta-naphthoflavone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Beta-naphthoflavone increases the expression of ABCB6 [29]

Patented Pharmaceutical Agent

  ICG-001

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ICG-001 inhibits the expression of ABCB6 [21]

Natural Product

  Vitallium

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Vitallium increases the expression of ABCB6 [20]

  Tobacco Smoke Pollution

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tobacco Smoke Pollution inhibits the expression of ABCB6 [24]

Traditional Medicine

  Jinfukang

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Jinfukang increases the expression of ABCB6 [23]

Environmental toxicant

  Polycyclic aromatic hydrocarbons

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Polycyclic aromatic hydrocarbons induces the activity of ABCB6 [1]

Cell System

Human liver-derived cell lines Huh7-ABCB6

  Polychlorinated dibenzodioxin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Polychlorinated dibenzodioxin increases the expression of ABCB6 [1]

Acute Toxic Substance

  Ochratoxin A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ochratoxin A inhibits the expression of ABCB6 [17]

  Acrylamide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Acrylamide inhibits the expression of ABCB6 [28]

  Antimycin A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Antimycin A increases the expression of ABCB6 [30]

  Paraquat

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Paraquat increases the expression of ABCB6 [31]

Carcinogen

  Methylcholanthrene

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Methylcholanthrene increases the expression of ABCB6 [1]

  Ethyl Methanesulfonate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ethyl Methanesulfonate increases the expression of ABCB6 [19]

  Benzo(a)pyrene

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Benzo(a)pyrene increases the expression of ABCB6 [32]

  Arsenic

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

sodium arsenite results in increased abundance of Arsenic co-treated with manganese chloride results in increased abundance of Manganese results in increased expression of ABCB6 mRNA [37]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

sodium arsenite results in increased abundance of Arsenic which results in increased expression of ABCB6 mRNA [37]

Regulation Mechanism

Transcription Factor Info

  Cadmium

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cadmium Chloride results in increased abundance of Cadmium which results in increased expression of ABCB6 mRNA [40]

Regulation Mechanism

Transcription Factor Info

Pesticide/Insecticide

  Clothianidin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Clothianidin inhibits the expression of ABCB6 [25]

Health and Environmental Toxicant

  Glycidamide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Glycidamide increases the expression of ABCB6 [16]

Herbicide

  Atrazine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Atrazine inhibits the expression of ABCB6 [18]
References
1 Polycyclic aromatic hydrocarbons (PAHs) mediate transcriptional activation of the ATP binding cassette transporter ABCB6 gene via the aryl hydrocarbon receptor (AhR). J Biol Chem. 2012 Sep 14;287(38):32054-68.
2 Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Toxicol In Vitro. 2009 Apr;23(3):466-75.
3 Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma. Head Neck. 2011 Jul;33(7):959-68.
4 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
5 Transcriptomics hit the target: Monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
6 Rifampin Regulation of Drug Transporters Gene Expression and the Association of MicroRNAs in Human Hepatocytes. Front Pharmacol. 2016 Apr 26;7:111.
7 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
8 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761.
9 Temozolomide induces activation of Wnt/beta-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278.
10 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975.
11 Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Sci Rep. 2020 Nov 26;10(1):20622.
12 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
13 Stem Cell Transcriptome Responses and Corresponding Biomarkers That Indicate the Transition from Adaptive Responses to Cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
14 Mitochondrial dysfunction induced by leflunomide and its active metabolite. Toxicology. 2018 Mar 1;396-397:33-45.
15 A novel flow cytometric HTS assay reveals functional modulators of ATP binding cassette transporter ABCB6. PLoS One. 2012;7(7):e40005.
16 Expression profile of human cells in culture exposed to glycidamide, a reactive metabolite of the heat-induced food carcinogen acrylamide. Toxicology. 2007 Oct 30;240(1-2):111-24.
17 Ochratoxin a lowers mRNA levels of genes encoding for key proteins of liver cell metabolism. Cancer Genomics Proteomics. 2008 Nov-Dec;5(6):319-32.
18 Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals. 2012;20(4):265-80.
19 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
20 Improving cytocompatibility of Co28Cr6Mo by TiO2 coating: gene expression study in human endothelial cells. J R Soc Interface. 2013 Jul 3;10(86):20130428.
21 Altering cancer transcriptomes using epigenomic inhibitors. Epigenetics Chromatin. 2015 Feb 24;8:9.
22 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
23 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
24 Comparison of cellular and transcriptomic effects between electronic cigarette vapor and cigarette smoke in human bronchial epithelial cells. Toxicol In Vitro. 2017 Dec;45(Pt 3):417-425.
25 The neonicotinoid insecticide Clothianidin adversely affects immune signaling in a human cell line. Sci Rep. 2017 Oct 18;7(1):13446.
26 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
27 Transcriptome and DNA methylation changes modulated by sulforaphane induce cell cycle arrest, apoptosis, DNA damage, and suppression of proliferation in human liver cancer cells. Food Chem Toxicol. 2020 Feb;136:111047.
28 Acrylamide exposure represses neuronal differentiation, induces cell apoptosis and promotes tau hyperphosphorylation in hESC-derived 3D cerebral organoids. Food Chem Toxicol. 2020 Oct;144:111643.
29 Aryl hydrocarbon receptor (AhR) agonist beta-naphthoflavone regulated gene networks in human primary trophoblasts. Reprod Toxicol. 2020 Sep;96:370-379.
30 Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors. Arch Toxicol. 2021 Feb;95(2):591-615.
31 CD34+ derived macrophage and dendritic cells display differential responses to paraquat. Toxicol In Vitro. 2021 Sep;75:105198.
32 New insights into BaP-induced toxicity: role of major metabolites in transcriptomics and contribution to hepatocarcinogenesis. Arch Toxicol. 2016 Jun;90(6):1449-58.
33 Global analysis of posttranscriptional gene expression in response to sodium arsenite. Environ Health Perspect. 2015 Apr;123(4):324-30.
34 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
35 Integration of transcriptomics, proteomics and metabolomics data to reveal the biological mechanisms of abrin injury in human lung epithelial cells. Toxicol Lett. 2019;312:1-10.
36 The ATP-binding cassette transporter ABCB6 is induced by arsenic and protects against arsenic cytotoxicity. Toxicol Sci. 2011;120(2):519-28.
37 Using transcriptomic signatures to elucidate individual and mixture effects of inorganic arsenic and manganese in human placental trophoblast HTR-8/SVneo cells. Toxicol Sci. 2025;203(2):216-226.
38 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017;8(1):1369-1391.
39 Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. Environ Int. 2021 Nov;156:106730.
40 Cadmium acute exposure induces metabolic and transcriptomic perturbations in human mature adipocytes. Toxicology. 2022;470:153153.
41 The human ABCB6 protein is the functional homologue of HMT-1 proteins mediating cadmium detoxification. Cell Mol Life Sci. 2019;76(20):4131-4144.
42 Role of transporter genes in cisplatin resistance. In Vivo. 2008;22(3):279-83.
43 In vitro expression of hard metal dust (WC-Co)--responsive genes in human peripheral blood mononucleated cells. Toxicol Appl Pharmacol. 2008;227(2):299-312.
44 Transcription and splicing regulation in human umbilical vein endothelial cells under hypoxic stress conditions by exon array. BMC Genomics. 2009;10:126.
45 Genome-wide analysis discloses reversal of the hypoxia-induced changes of gene expression in colon cancer cells by zinc supplementation. Oncotarget. 2011;2(12):1191-202.
46 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
47 Alterations in the proteomes of HepG2 and IHKE cells inflicted by six selected mycotoxins. Arch Toxicol. 2025;99(2):701-715.
48 L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines. Toxicol Lett. 2010 Feb 15;192(3):408-18.
49 Comparative Analysis of Transcriptomic Changes including mRNA and microRNA Expression Induced by the Xenoestrogens Zearalenone and Bisphenol A in Human Ovarian Cells. Toxins (Basel). 2023;15(2).
50 Expression of ABCB6 is related to resistance to 5-FU, SN-38 and vincristine. Anticancer Res. 2014;34(9):4767-73.
51 Identification of a mammalian mitochondrial porphyrin transporter. Nature. 2006;443(7111):586-9.
52 High-throughput, quantitative assessment of the effects of low-dose silica nanoparticles on lung cells: grasping complex toxicity with a great depth of field. BMC Genomics. 2015;16(1):315.
53 High-Throughput Transcriptomics of Nontumorigenic Breast Cells Exposed to Environmentally Relevant Chemicals. Environ Health Perspect. 2024;132(4):47002.
54 CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. Toxicol Appl Pharmacol. 2020;386:114828.
55 Identification of novel low-dose bisphenol a targets in human foreskin fibroblast cells derived from hypospadias patients. PLoS One. 2012;7(5):e36711.
56 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.